J
Jean-Claude Louis
Researcher at Amgen
Publications - 23
Citations - 4103
Jean-Claude Louis is an academic researcher from Amgen. The author has contributed to research in topics: Neurotrophic factors & Glial cell line-derived neurotrophic factor. The author has an hindex of 16, co-authored 23 publications receiving 3938 citations.
Papers
More filters
Journal ArticleDOI
GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF
Shuqian Jing,Duanzhi Wen,Yanbin Yu,Paige Holst,Yi Luo,Mei Fang,Rami Tamir,Laarni Antonio,Zheng Hu,Rod Cupples,Jean-Claude Louis,Sylvia Hu,Bruce W. Altrock,Gary M. Fox +13 more
TL;DR: In this paper, the expression cloning and characterization of GDNFR-α, a novel glycosylphosphatidylinositol-linked cell surface receptor for glial cell line-derived neurotrophic factor (GDNF), was reported.
Journal ArticleDOI
Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation
Linda O. Narhi,Stephen J. Wood,Shirley Steavenson,Yijia Jiang,Dan Anafi,Stephen Kaufman,Francis Hall Martin,Karen C. Sitney,Paul Denis,Jean-Claude Louis,Jette Wypych,Anja Leona Biere,Martin Citron +12 more
TL;DR: It is shown that both wild type and mutant α-synuclein form insoluble fibrillar aggregates with antiparallel β-sheet structure upon incubation at physiological temperature in vitro, and that aggregate formation is accelerated by both PD-linked mutations.
Journal ArticleDOI
alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.
Stephen J. Wood,Jette Wypych,Shirley Steavenson,Jean-Claude Louis,Martin Citron,Anja Leona Biere +5 more
TL;DR: It is suggested that differences in aggregation kinetics of alpha-synucleins cannot be explained by differences in solubility but are due to different nucleation rates, and alpha- Synuclein nucleation may be the rate-limiting step for the formation of Lewy body alpha- synuclein fibrils in Parkinson's disease.
Journal ArticleDOI
The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation
Narender R. Gavva,Anthony W. Bannon,Sekhar Surapaneni,David N. Hovland,Sonya G. Lehto,Anu Gore,Todd Juan,Hong Deng,Bora Han,Lana Klionsky,Rongzhen Kuang,April Le,Rami Tamir,Jue Wang,Brad Youngblood,Dawn Zhu,Mark H. Norman,Ella Magal,James J. S. Treanor,Jean-Claude Louis +19 more
TL;DR: It is reported that TRPV1 antagonists representing various chemotypes cause an increase in body temperature (hyperthermia), identifying a potential issue for their clinical development and indicating that tonic TRPv1 activation regulates body temperature.
Journal ArticleDOI
Nonthermal Activation of Transient Receptor Potential Vanilloid-1 Channels in Abdominal Viscera Tonically Inhibits Autonomic Cold-Defense Effectors
Alexandre A. Steiner,Victoria F Turek,Maria Camila Almeida,Jeffrey J. Burmeister,Daniela L. Oliveira,Jennifer L. Roberts,Anthony W. Bannon,Mark H. Norman,Jean-Claude Louis,James J. S. Treanor,Narender R. Gavva,Andrej A. Romanovsky +11 more
TL;DR: It is concluded that tonic activation of TRPV1 channels in the abdominal viscera by yet unidentified nonthermal factors inhibits skin vasoconstriction and thermogenesis, thus having a suppressive effect on Tb.